Lifecore Biomedical, Inc. De (LFCR) Long-Term Investments (2011 - 2021)

Lifecore Biomedical's Long-Term Investments history runs 11 years deep, the most recent figure standing at $44.8 million for Q2 2021.

• In Q2 2021, Long-Term Investments fell 21.32% year-over-year to $44.8 million; the TTM figure through May 2021 stood at $44.8 million (down 21.32% YoY), while the FY2021 annual figure was $44.8 million, down 21.32% from the prior year.
• Long-Term Investments was $44.8 million for Q2 2021 at Lifecore Biomedical, down from $45.1 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $68.1 million in Q4 2018 to a low of $44.8 million in Q2 2021.
• Historically, Long-Term Investments has averaged $60.3 million across 5 years, with a median of $62.4 million in 2017.
• The sharpest annual moves came in 2017 and 2020: Long-Term Investments grew 4.94% in 2017, then fell 26.43% in 2020.
• A 5-year view of Long-Term Investments shows it stood at $65.8 million in 2017, then gained by 3.5% to $68.1 million in 2018, then fell by 9.99% to $61.3 million in 2019, then dropped by 26.43% to $45.1 million in 2020, then slipped by 0.73% to $44.8 million in 2021.
• The last three Long-Term Investments figures came in at $44.8 million (Q2 2021), $45.1 million (Q1 2021), and $45.1 million (Q4 2020), per Business Quant data.